Fenofibrate reduces osteonecrosis without affecting antileukemic efficacy in dexamethasone-treated mice.

Haematologica
Emily R FinchLaura J Janke

Abstract

Recent clinical trials in children with acute lymphoblastic leukemia (ALL) indicate that severe hypertriglyceridemia (> 1000 mg/dL) during therapy is associated with increased frequency of symptomatic osteonecrosis. Interventions to lower triglycerides have been considered, but there have been no pre-clinical studies investigating impact of lowering triglycerides on osteonecrosis risk, nor whether such interventions interfere with the antileukemic efficacy of ALL treatment. We utilized our clinically relevant mouse model of dexamethasone-induced osteonecrosis to determine if fenofibrate decreased osteonecrosis. To test whether fenofibrate affected the antileukemic efficacy of dexamethasone, we utilized a BCR-ABL+ model of ALL. Serum triglycerides were reduced with fenofibrate throughout treatment, with the most pronounced 4.5-fold decrease at week 3 (p<1x10-6). Both frequency (33% versus 74%, p=0.006) and severity (median necrosis score of 0 versus 75; p=6x10-5) of osteonecrosis were reduced with fenofibrate. Fenofibrate had no impact on BCR-ABL+ ALL survival (p=0.65) nor on the antileukemic properties of dexamethasone (p=0.49). These data suggest that lowering triglycerides with fenofibrate reduces dexamethasone-induced osteon...Continue Reading

References

May 28, 1992·The New England Journal of Medicine·H J Mankin
Jan 1, 1985·European Journal of Clinical Pharmacology·C R SirtoriE Bosisio
Jan 1, 1985·Archives of Disease in Childhood·K A WheelerJ Barley
Apr 27, 1981·Clinica Chimica Acta; International Journal of Clinical Chemistry·J SteinmetzP Drouin
Aug 1, 1996·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C ItoD Campana
Nov 10, 1998·Circulation·B StaelsJ C Fruchart
Sep 29, 1999·European Journal of Clinical Pharmacology·A BranchiD Sommariva
May 12, 2001·Clinical Orthopaedics and Related Research·J W Pritchett
Jul 13, 2002·Arthritis and Rheumatism·Takehiro MuraiTadamasa Hanyu
Apr 19, 2006·Proceedings of the National Academy of Sciences of the United States of America·Richard T WilliamsCharles J Sherr
Mar 21, 2007·The American Journal of Cardiology·Michael H DavidsonTerry A Jacobson
Aug 8, 2008·Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society·Lei YangMary V Relling
Apr 11, 2009·The Orthopedic Clinics of North America·Muhammad AjmalEdward Y Cheng
Oct 6, 2009·The Journal of Biological Chemistry·Maaike H OosterveerDirk-Jan Reijngoud
Apr 1, 2008·Journal of Clinical Lipidology·Courtney M Smalley, Stanley J Goldberg
Aug 26, 2011·Metabolism: Clinical and Experimental·Ashley J PeckettMichael C Riddell
Sep 29, 2011·Drugs·Kate McKeage, Gillian M Keating
Nov 16, 2011·Pediatrics·UNKNOWN Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents, UNKNOWN National Heart, Lung, and Blood Institute
Aug 8, 2012·Expert Opinion on Drug Safety·Stefano Bellosta, Alberto Corsini
May 1, 2013·Biochimica Et Biophysica Acta·Jianfeng HuangGerald Hoefler
May 16, 2013·The American Journal of Pathology·Laura J JankeMary V Relling
Apr 9, 2014·Pharmacogenetics and Genomics·Laura B RamseyMary V Relling
Aug 5, 2014·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Deepa BhojwaniMonika L Metzger
Mar 12, 2016·PloS One·Chengcheng LiuMary V Relling
Jul 16, 2016·Journal of the American College of Cardiology·Joost BesselingBarbara A Hutten
Oct 19, 2016·Circulation·Barbara S WigginsUNKNOWN American Heart Association Clinical Pharmacology Committee of the Council on Clinical Cardiology; Council on Hypertension; C
Oct 24, 2017·Expert Opinion on Drug Safety·Stefano Bellosta, Alberto Corsini
Nov 10, 2017·Scientific Reports·Yuma SakamotoShiro Ikegawa
Dec 8, 2017·Lipids in Health and Disease·Jia PengXiangping Li

❮ Previous
Next ❯

Citations

Mar 16, 2021·HemaSphere·Michaela KuhlenNicola Gökbuget

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Nihon rinsho. Japanese journal of clinical medicine
T Yamashita, H Nakamura
Hospital Practice
W V Brown
Der Orthopäde
Marcus Jäger
© 2021 Meta ULC. All rights reserved